Jeffrey W. Albers, Director: Blueprint Medicines BPMC Sell · Filed 23/09/29

Trade details

Type: Insider sale
Amount: $604,252.86
Shares · price: 12,102 sh · $49.93 a share
Held after: 176,450 sh
Stock: Blueprint Medicines BPMC
Person: Jeffrey W. AlbersDirector
Trade date: 23/09/27
Filed: 23/09/29
Days to filing: 2 days

Sold 6.4% of holdings

Share of holding sold: 6.4%

Blueprint Medicines trades, last 26 weeks

What else happened in Blueprint Medicines around then

Filed or reported within 30 days of the trade day · 23/08/28~23/10/27

Jeffrey W. Albers's recent trades

Jeffrey W. AlbersDirector
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$517.1K
5,000 sh
$517.1K
Filed 08/07
Traded 08/07
Jeffrey W. AlbersDirector
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$1.9M
18,000 sh
$1.9M
Filed 08/07
Traded 08/07
Jeffrey W. AlbersDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$245.5K
2,748 sh
$245.5K
Filed 25/12/08
Traded 25/12/08
Jeffrey W. AlbersDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$203.4K
2,252 sh
$203.4K
Filed 25/12/08
Traded 25/12/08
Jeffrey W. AlbersDirector
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$333.1K
5,000 sh
$333.1K
Filed 25/12/08
Traded 25/12/08